CoChat

PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion

Open access
Nahi, H., Merup, M., Lehmann, S., Bengtzen, S., Möllgård, L., Selivanova, G., Wiman, K. G., Paul, C. · 2006 · British Journal of Haematology
Cited by 62

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: The p53 tumour suppressor gene located on chromosome 17p13 is the most frequently mutated gene in human tumours. About 5–8% of cases with acute myeloid leukaemia (AML) carry the p53 mutation. Recently, the compound p53‐dependent reactivation and induction of massive apoptosis (PRIMA‐1) has been shown to induce cytotoxic effects and apoptosis in human tumour cells by restoration of the transcriptional activity of mutated p53. This is believed to be mediated by a change in the conformation of mutated p53 protein, restoring DNA binding and activation of p53 target genes. We studied the effects of PRIMA‐1 and commonly used antileukaemic drugs on AML cells from 62 patients. Cells were obtained from peripheral blood or bone marrow and were exposed to PRIMA‐1, cytarabine, daunorubicin, chlorodeoxyadenosine and fludarabine. This study showed that PRIMA‐1 had cytotoxic effects on AML cells. Conventional AML drugs were less effective in cells with hemizygous p53 deletion. Interestingly, our data indicated that PRIMA‐1 was more effective in this subgroup of patients compared with patients with normal chromosome 17. Our data suggest that the concept of restoration of p53 protein by PRIMA‐1 or a PRIMA‐1‐based new drug may increase the efficacy of AML treatment in patients with p53 mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2141.2005.05851.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 35

  1. 10.1038/nm0796-811 · DOI · Paper page
  2. Andreotti P.E., 1995, Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma, Cancer Research, 55, 5276
  3. Broxterman H.J., 1997, Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukemia, Journal of Internal Medicine Supplement, 740, 147, 10.1111/joim.1997.242.s740.147 · doi:10.1111/joim.1997.242.s740.147
  4. 10.1093/carcin/23.12.2011 · DOI · Paper page
  5. 10.1182/blood.V79.2.473.473 · DOI · Paper page
  6. 10.1097/00001813-199906000-00002 · doi:10.1097/00001813-199906000-00002
  7. 10.1038/35077213 · DOI · Paper page
  8. Fenaux P., 1991, P53 gene mutations in acute myeloid leukemia with 17p monosomy, Blood, 78, 1652, 10.1182/blood.V78.7.1652.1652 · DOI · Paper page
  9. 10.1016/S0145-2126(01)00107-2 · DOI
  10. Gerlach J.H., 1986, Multidrug resistance, Cancer Surveys, 5, 25
  11. 10.1016/0959-8049(96)00057-3 · DOI · Paper page
  12. 10.1182/blood.V83.9.2637.2637 · doi:10.1182/blood.v83.9.2637.2637
  13. 10.1056/NEJM199310283291807 · DOI · Paper page
  14. 10.1111/j.1365-2141.1992.tb02979.x · DOI · Paper page
  15. 10.1016/0006-2952(94)00511-J · doi:10.1016/0006-2952(94)00511-j
  16. Kangas L., 1984, Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro, Medical Biology, 62, 338
  17. 10.1101/gad.10.9.1054 · DOI · Paper page
  18. Lai J.L., 1995, Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations, Leukemia, 9, 370
  19. 10.1128/MCB.6.5.1379 · DOI · Paper page
  20. 10.1182/blood.V78.3.586.586 · DOI · Paper page
  21. 10.1111/j.1365-2141.2004.05210.x · DOI · Paper page
  22. Peng L., 2002, Detection of B lymphoma cells undergoing apoptosis by Annexin‐V assay, Chinese Medical Sciences Journal, 17, 17
  23. 10.1097/00001813-199709000-00006 · doi:10.1097/00001813-199709000-00006
  24. 10.1093/jnci/83.10.708 · DOI · Paper page
  25. 10.1016/0145-2126(93)90011-9 · doi:10.1016/0145-2126(93)90011-9
  26. 10.1182/blood.V91.3.1008 · DOI · Paper page
  27. 10.1006/gyno.1995.1190 · DOI
  28. 10.1182/blood.V97.11.3589 · DOI · Paper page
  29. 10.1016/0145-2126(93)90022-D · doi:10.1016/0145-2126(93)90022-d
  30. Tidefelt U., 1992, Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia, Cancer Research, 52, 3281
  31. 10.1007/s002800050514 · doi:10.1007/s002800050514
  32. 10.1002/ajh.2830460409 · DOI · Paper page
  33. Twentyman P.R., 1997, Transport proteins in drug resistance: biology and approaches to circumvention, Journal of Internal Medicine Supplement, 740, 133, 10.1111/joim.1997.242.s740.133 · doi:10.1111/joim.1997.242.s740.133
  34. 10.1182/blood.V84.9.3148.3148 · DOI · Paper page
  35. Zochbauer S., 1994, P‐glycoprotein expression as unfavorable prognostic factor in acute myeloid leukemia, Leukemia, 8, 974

Cited by

See all 62

Metadata

Authors
Nahi, H., Merup, M., Lehmann, S., Bengtzen, S., Möllgård, L., Selivanova, G., Wiman, K. G., & Paul, C.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2005-12-09
Volume
132
Issue
2
Pages
230-236
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W1965739405
Cited by
62
References
2
FWCI
0.71
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. https://app.cochat.ai/papers/10.1111/j.1365-2141.2005.05851.x
The paper
Nahi, H., Merup, M., Lehmann, S., Bengtzen, S., Möllgård, L., Selivanova, G., Wiman, K. G., & Paul, C. (2006). PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2005.05851.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.